Brain Computer Interface

Brain-Computer Interfaces (BCIs) — devices that establish direct communication between the brain's electrical activity and external computers — have moved from science fiction to clinical reality in the 2020s. The technology works by recording electrical activity from neurons (either with implanted electrodes in the brain or non-invasive EEG from the scalp), decoding the pattern into computational commands, and feeding back results to the user. The key application driving the field: restoring communication and movement to paralyzed people. Major milestones: BrainGate (2004, first human trials — Matthew Nagle, paralyzed, controlled a computer cursor and TV with implanted electrode array); NeuraLink's first human patient (January 2024 — Noland Arbaugh, quadriplegic, playing chess and video games by thinking, 1,024 electrodes implanted); Stanford's NeuroPace (closed-loop stimulation for epilepsy, FDA approved 2013); and cochlear implants (1.5 million people, FDA approved 1984 — technically the first mass-market BCI). Non-medical applications: Elon Musk's vision of 'AI symbiosis' (humans augmented by BCIs to keep pace with AI); CTRL-Labs armband (decodes hand movements from peripheral nerve signals, acquired by Meta for $1B); and BCI-powered prosthetics that provide tactile feedback. The ethical questions (privacy of thoughts, coercion, identity) are profound.